<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Public Health">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Public Health</JournalTitle>
      <Issn>2251-6085</Issn>
      <Volume>34</Volume>
      <Issue>Supple 1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2005</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Diagnostic Value of Perinuclear Antineutrophil Cytoplasmic Antibody and Anti-Saccharomyces Cerevisiae Antibody and their Relationship with inflammatory Bowel disease Characteristics in Iranian Patients</title>
    <FirstPage>68</FirstPage>
    <LastPage>69</LastPage>
    <AuthorList>
      <Author>
        <FirstName></FirstName>
        <LastName>M Aarabi</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>A Bahari</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>M Hedayati</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>A Jarollahi</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>M Habibi</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>R Aghazadeh</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>MR Zali</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>03</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Introduction: Inflammatory bowel disease (IBD) has two major groups: Ulcerative Colitis (UC) and Crohn&#x2019;s Disease (CD), diagnosed by routine invasive methods. In recent years, diagnostic value of immunologic tests including perinuclear Antineutrophil Cytoplasmic Antibody (pANCA) and Anti-Saccharomyces Cerevisiae Antibody (ASCA) has been mentioned. These tests are supposed to be used as a diagnostic tool and also have some relationship with clinical characteristics of IBD.In this study; we investigated the diagnostic value of above tests and their relationship with IBD manifestations. Methods: Sera from 144 patients with IBD (113 with UC and 31 with CD) as cases and 176 patients with non-IBD rectorrhagia, flatulence, dyspepsia, GI cancers, IBS as controls were analyzed. Patients&#x2019; serum was assayed for ASCA by Enzyme-Linked Immunosorbent Assay (ELISA) &amp; for pANCA by indirect immunofluorescence assay (IFA). Results: Sensitivity, specificity, positive and negative predictive value of pANCA in UC were: 39%, 82%, 70%, and 56%. In patients with CD the above parameters were: 58%, 70%, 31%, and 87%, respectively. Using both tests increased the specificity and positive predictive value in UC patients to 89% and 84% and in patients with CD to 80% and 46%. There was a significant difference between CD and UC groups in ASCA results (P= 0.002).UC patients with Sclerosing Cholangitis (P=0.003) and severe bleeding (P=0.004) were significantly positive for pANCA more than other UC patients, respectively. Conclusion: We recommend pANCA &amp; ASCA for differentiation of CD &amp; UC, although it is not useful for screening. Using both tests together improves the specificity and positive predictive value. Positive pANCA results might be seen together with some complications like: Sclerosing Cholangitis &amp; severe bleeding.</abstract>
    <web_url>https://ijph.tums.ac.ir/index.php/ijph/article/view/3000</web_url>
  </Article>
</Articles>
